SCÈNES ET MŒURS DES RIVES ET DES COTES. LE MARINIER DE LOIRE

Autor: Souvestre, Émile

Publikováno v: Revue des Deux Mondes (1829-1971), 1852 Feb 01. 13(3), 421-459.

Externí odkaz: https://www.jstor.org/stable/44692686

Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.

Autor: McLouth LE; Department of Behavioral Science, College of Medicine, Markey Cancer Center, University of Kentucky, 467 Healthy Kentucky Research Building, 760 Press Avenue, Lexington, KY, 40508, USA. Laurie.mclouth@uky.edu., Zheng Y; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Smith S; Nancy N. and J.C. Lewis Cancer and Research Pavilion, St. Joseph's/Candler, Savannah, GA, USA., Hodi FS; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA.; Dana-Farber Cancer Institute/Harvard Cancer Center, Boston, MA, USA., Rao UN; University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Cohen GI; Greater Baltimore Medical Center, Baltimore, MD, USA., Amatruda TT; Minnesota Oncology, Fridley, MN, USA., Dakhil SR; Ascension Via Christi Hospitals, Wichita, KS, USA., Curti BD; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Nakhoul I; Regional Cancer Center at Indian Path Community Hospital, Kingsport, TN, USA., Chandana SR; Cancer and Hematology Centers of Western Michigan/Cancer Research Consortium of West Michigan NCORP, Grand Rapids, MI, USA., Bane CL; Good Samaritan Hospital-Dayton, Dayton, OH, USA., Marinier DE; Gundersen Health System, La Crosse, WI, USA., Lee SJ; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Sondak VK; Moffitt Cancer Center, Tampa, FL, USA., Kirkwood JM; University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Tarhini AA; Moffitt Cancer Center, Tampa, FL, USA., Wagner LI; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.

Publikováno v: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Jan; Vol. 32 (1), pp. 183-196. Date of Electronic Publication: 2022 Aug 27.

Durable Response After 2 Doses of Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer With an Isolated Brain Metastasis.

Autor: Uprety D; Gundersen Health System, La Crosse, WI. Electronic address: upretydipesh@gmail.com., Arjyal L; Gundersen Health System, La Crosse, WI., Vallatharasu Y; Gundersen Health System, La Crosse, WI., Bista A; Gundersen Health System, La Crosse, WI., Wittchow RJ; Gundersen Health System, La Crosse, WI., Marinier DE; Gundersen Health System, La Crosse, WI.

Publikováno v: Clinical lung cancer [Clin Lung Cancer] 2019 Sep; Vol. 20 (5), pp. e552-e554. Date of Electronic Publication: 2019 Jun 13.

Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era.

Autor: Uprety D; Department of Medical Oncology, Gundersen Health System, La Crosse, WI, U.S.A. upretydipesh@gmail.com., Bista A; Department of Medical Oncology, Gundersen Health System, La Crosse, WI, U.S.A., Smith AL; Division of Medical Research, Gundersen Lutheran Medical Foundation, La Crosse, WI, U.S.A., Vallatharasu Y; Department of Medical Oncology, Gundersen Health System, La Crosse, WI, U.S.A., Marinier DE; Department of Medical Oncology, Gundersen Health System, La Crosse, WI, U.S.A.

Publikováno v: Anticancer research [Anticancer Res] 2018 May; Vol. 38 (5), pp. 3013-3018.

Refractory cytopenias with unilineage dysplasia: a retrospective analysis of refractory neutropenia and refractory thrombocytopenia.

Autor: Marinier DE, Mesa H, Rawal A, Gupta P

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2010 Oct; Vol. 51 (10), pp. 1923-6.